NewGen Announces Closing of $1.25 Million Public Offering
Key Highlights
- ➤NewGenIVF (NIVF) closed public offering with approximately $1.25 million gross proceeds
- ➤Offering included 17,857,143 Class A Ordinary Shares or pre-funded warrants
- ➤Public offering priced at $0.07 per share and $0.06999 per pre-funded warrant
- ➤Proceeds target K25.ai investment, debt restructuring, Nodexus manufacturing, and working capital
- ➤Transaction closed September 30, 2026
BANGKOK, Oct. 01, 2026 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ: NIVF) (the “Company”), a tech-forward, diversified, multi-jurisdictional high-growth entity transforming industries through innovative solutions across real estate development, digital asset management and reproductive health solutions, today announced the closing of its previously announced public offering made on a reasonable best efforts basis with gross proceeds to the Company of approximately $1.25 million, before deducting placement agent fees and other offering expenses payable by the Company.
The offering consisted of an aggregate of 17,857,143 Class A Ordinary Shares or pre-funded warrants to purchase Class A Ordinary Shares in lieu thereof (the “Pre-Funded Warrants”), comprising 125,000 Class A Ordinary Shares and Pre-Funded Warrants to purchase up to 17,732,143 Class A Ordinary Shares. The public offering price was $0.07 per Class A Ordinary Share and $0.06999 per Pre-Funded Warrant, which equals the public offering price per Class A Ordinary Share less the $0.00001 per share exercise price of the Pre-Funded Warrant. The Pre-Funded Warrants are immediately exercisable and may be exercised at any time until exercised in full.
Get started
Create a free account to read the full story.
